Canadian Company STEMCELL Technologies Is an Essential Industry Partner for COVID-19 Research and Vaccine Development – Vancouver Sun
stemadminStem Cell ResearchNo comments

About STEMCELL Technologies STEMCELL Technologies is Canadas largest biotechnology company, with over 1,500 employees and year-on-year growth of approximately 20% for the last 26 years. Based in Vancouver, STEMCELL supports life sciences research around the world with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources that are used by scientists advancing the stem cell, immunology, cancer, regenerative medicine, microbiology, and cellular therapy fields

Read more
Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Explores The Key Success Factors, And Business Opportunities Including Key…
stemadminStem Cell ResearchNo comments

Transparency Market Research (TMR) has published a new report titled Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20182026. According to the report, theglobal platelet rich plasma & stem cell alopecia treatment marketwas valued at approximately US$ 250Mn in 2017. The market is anticipated to reach a value of US$ 450.5 Mn by 2026, expanding at a higher single digit CAGR during the forecast period

Read more
Animal Stem Cell Therapy Market 2020 Primary Research, Secondary Research, Product Research, Trends and Forecast 2025 – Pro News Time
stemadminStem Cell ResearchNo comments

The report offers in-depth analysis of the global Animal Stem Cell Therapy market taking into account market dynamics, segmentation, geographical expansion, competitive landscape, and various other key aspects. The market analysts who have prepared the report have thoroughly studied the global Animal Stem Cell Therapy market and have offered reliable and accurate data.

Read more
MicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair – GlobeNewswire
stemadminStem Cell ResearchNo comments

NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the bodys innate regenerative mechanisms to accelerate tissue repair, today announced that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).

Read more
International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019 – Associated Press
stemadminStem Cell ResearchNo comments

Press release content from ACCESSWIRE. The AP news staff was not involved in its creation. Click to copy CARLSBAD, CA / ACCESSWIRE / November 15, 2019 / International Stem Cell Corporation (OTCQB:ISCO) ( http://www.internationalstemcell.com ) (ISCO or the Company), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today announced operating results for the three and nine months ended September 30, 2019.

Read more
NIST researchers use artificial intelligence for quality control of stem cell-derived tissues – National Institutes of Health
stemadminStem Cell ResearchNo comments

News Release Thursday, November 14, 2019 Technique key to scale up manufacturing of therapies from induced pluripotent stem cells. Researchers used artificial intelligence (AI) to evaluate stem cell-derived patches of retinal pigment epithelium (RPE) tissue for implanting into the eyes of patients with age-related macular degeneration (AMD), a leading cause of blindness. The proof-of-principle study helps pave the way for AI-based quality control of therapeutic cells and tissues.

Read more

Theme: Illdy.